Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

RSS icon

Cardiologists urge heart disease patients to seek emergency care when necessary

Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.

June 2, 2020
heart.png

FDA approves use of ticagrelor for high-risk CAD patients

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

June 2, 2020

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

May 21, 2020
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.

Heart attack care is different for male and female patients—and the inconsistency can lead to fatal results

Women are prescribed fewer drugs after a heart attack than men—and they are more likely to die afterward as a result of that disparity.

April 23, 2020

CAD deaths on the rise among young women in rural areas

Women in rural parts of the United States have experienced an increase in premature coronary artery disease (CAD) mortality, according to new findings published in the Journal of the American Heart Association.

April 22, 2020

How should physicians treat STEMI patients with COVID-19? A new study aims to find out

A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

April 8, 2020

FDA approves new solution for reducing heart muscle damage after serious heart attacks

ZOLL Medical Corporation has gained FDA approval for its new SuperSaturated Oxygen (SSO2) therapy solution for treating heart muscle damage in “widowmaker” heart attacks patients.

March 31, 2020
Homeless man

Fewer treatments, higher readmission rates: Tracking outcomes for homeless patients after heart attacks

Homeless patients receive fewer treatments and experience higher readmission rates when hospitalized for a heart attack than other patients, according to new findings published in Mayo Clinic Proceedings.

March 25, 2020
Displaying 305 - 312 of 610

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup